Standard BioTools (LAB) announced that Institutional Shareholder Services has recommended that Standard BioTools stockholders vote “FOR” all proposals relating to the pending merger with SomaLogic (SLGC) at the company’s upcoming Special Meeting of Stockholders to be held on January 4, 2024. The company issued the following statement: “Our merger with SomaLogic presents a compelling value proposition for all stockholders through a significantly accelerated path to profitability and bolstered capital structure to fuel future growth. We are pleased with ISS’ recommendation and look forward to completing the merger in the first quarter of 2024.”
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SLGC:
- ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools
- SomaLogic urges stockholders to vote for Standard BioTools merger
- SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools
- Madryn issues letter to holders correcting SomaLogic statements in presentation
- Skye Fund III issues letter regarding opposition of SomaLogic’s proposed merger